525 related articles for article (PubMed ID: 21321941)
1. The regulatory role of histone deacetylase inhibitors in Fgf4 expression is dependent on the differentiation state of pluripotent stem cells.
Shi G; Gao F; Jin Y
J Cell Physiol; 2011 Dec; 226(12):3190-6. PubMed ID: 21321941
[TBL] [Abstract][Full Text] [Related]
2. Foxa1 contributes to the repression of Nanog expression by recruiting Grg3 during the differentiation of pluripotent P19 embryonal carcinoma cells.
Chen T; He S; Zhang Z; Gao W; Yu L; Tan Y
Exp Cell Res; 2014 Aug; 326(2):326-35. PubMed ID: 24803390
[TBL] [Abstract][Full Text] [Related]
3. Artd1/Parp1 regulates reprogramming by transcriptional regulation of Fgf4 via Sox2 ADP-ribosylation.
Weber FA; Bartolomei G; Hottiger MO; Cinelli P
Stem Cells; 2013 Nov; 31(11):2364-73. PubMed ID: 23939864
[TBL] [Abstract][Full Text] [Related]
4. PARP1 poly(ADP-ribosyl)ates Sox2 to control Sox2 protein levels and FGF4 expression during embryonic stem cell differentiation.
Gao F; Kwon SW; Zhao Y; Jin Y
J Biol Chem; 2009 Aug; 284(33):22263-22273. PubMed ID: 19531481
[TBL] [Abstract][Full Text] [Related]
5. BRG1 Governs Nanog Transcription in Early Mouse Embryos and Embryonic Stem Cells via Antagonism of Histone H3 Lysine 9/14 Acetylation.
Carey TS; Cao Z; Choi I; Ganguly A; Wilson CA; Paul S; Knott JG
Mol Cell Biol; 2015 Dec; 35(24):4158-69. PubMed ID: 26416882
[TBL] [Abstract][Full Text] [Related]
6. Chromatin states of core pluripotency-associated genes in pluripotent, multipotent and differentiated cells.
Barrand S; Collas P
Biochem Biophys Res Commun; 2010 Jan; 391(1):762-7. PubMed ID: 19944068
[TBL] [Abstract][Full Text] [Related]
7. Nanog requires BRD4 to maintain murine embryonic stem cell pluripotency and is suppressed by bromodomain inhibitor JQ1 together with Lefty1.
Horne GA; Stewart HJ; Dickson J; Knapp S; Ramsahoye B; Chevassut T
Stem Cells Dev; 2015 Apr; 24(7):879-91. PubMed ID: 25393219
[TBL] [Abstract][Full Text] [Related]
8. The histone deacetylase SIRT6 controls embryonic stem cell fate via TET-mediated production of 5-hydroxymethylcytosine.
Etchegaray JP; Chavez L; Huang Y; Ross KN; Choi J; Martinez-Pastor B; Walsh RM; Sommer CA; Lienhard M; Gladden A; Kugel S; Silberman DM; Ramaswamy S; Mostoslavsky G; Hochedlinger K; Goren A; Rao A; Mostoslavsky R
Nat Cell Biol; 2015 May; 17(5):545-57. PubMed ID: 25915124
[TBL] [Abstract][Full Text] [Related]
9. Orphan nuclear receptor GCNF is required for the repression of pluripotency genes during retinoic acid-induced embryonic stem cell differentiation.
Gu P; LeMenuet D; Chung AC; Mancini M; Wheeler DA; Cooney AJ
Mol Cell Biol; 2005 Oct; 25(19):8507-19. PubMed ID: 16166633
[TBL] [Abstract][Full Text] [Related]
10. Stable expression of FoxA1 promotes pluripotent P19 embryonal carcinoma cells to be neural stem-like cells.
Dong D; Meng L; Yu Q; Tan G; Ding M; Tan Y
Gene Expr; 2012; 15(4):153-62. PubMed ID: 22783724
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional reprogramming and chromatin remodeling accompanies Oct4 and Nanog silencing in mouse trophoblast lineage.
Carey TS; Choi I; Wilson CA; Floer M; Knott JG
Stem Cells Dev; 2014 Feb; 23(3):219-29. PubMed ID: 24059348
[TBL] [Abstract][Full Text] [Related]
12. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.
Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J
Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998
[TBL] [Abstract][Full Text] [Related]
13. Tgif1 Counterbalances the Activity of Core Pluripotency Factors in Mouse Embryonic Stem Cells.
Lee BK; Shen W; Lee J; Rhee C; Chung H; Kim KY; Park IH; Kim J
Cell Rep; 2015 Oct; 13(1):52-60. PubMed ID: 26411691
[TBL] [Abstract][Full Text] [Related]
14. Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells.
Choi SC; Choi JH; Park CY; Ahn CM; Hong SJ; Lim DS
J Cell Physiol; 2012 Nov; 227(11):3678-92. PubMed ID: 22378194
[TBL] [Abstract][Full Text] [Related]
15. Dual roles of histone H3 lysine 9 acetylation in human embryonic stem cell pluripotency and neural differentiation.
Qiao Y; Wang R; Yang X; Tang K; Jing N
J Biol Chem; 2015 Jan; 290(4):2508-20. PubMed ID: 25519907
[TBL] [Abstract][Full Text] [Related]
16. Role of SOX2 in maintaining pluripotency of human embryonic stem cells.
Adachi K; Suemori H; Yasuda SY; Nakatsuji N; Kawase E
Genes Cells; 2010 May; 15(5):455-70. PubMed ID: 20384793
[TBL] [Abstract][Full Text] [Related]
17. Depletion of embryonic stem cell signature by histone deacetylase inhibitor in NCCIT cells: involvement of Nanog suppression.
You JS; Kang JK; Seo DW; Park JH; Park JW; Lee JC; Jeon YJ; Cho EJ; Han JW
Cancer Res; 2009 Jul; 69(14):5716-25. PubMed ID: 19567677
[TBL] [Abstract][Full Text] [Related]
18. The RNA-binding protein Unr prevents mouse embryonic stem cells differentiation toward the primitive endoderm lineage.
Elatmani H; Dormoy-Raclet V; Dubus P; Dautry F; Chazaud C; Jacquemin-Sablon H
Stem Cells; 2011 Oct; 29(10):1504-16. PubMed ID: 21954113
[TBL] [Abstract][Full Text] [Related]
19. Global epiproteomic signatures distinguish embryonic stem cells from differentiated cells.
Dai B; Rasmussen TP
Stem Cells; 2007 Oct; 25(10):2567-74. PubMed ID: 17641388
[TBL] [Abstract][Full Text] [Related]
20. A positive regulatory role for the mSin3A-HDAC complex in pluripotency through Nanog and Sox2.
Baltus GA; Kowalski MP; Tutter AV; Kadam S
J Biol Chem; 2009 Mar; 284(11):6998-7006. PubMed ID: 19139101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]